Abstract
Aims
The standard treatment of neonatal group B Streptococcus infection is intravenous amoxicillin for 10 days. We investigated whether effective serum amoxicillin concentrations could be reached by switching to oral amoxicillin after 48 h of intravenous administration in full-term neonates with group B Streptococcus infection.
Methods
Over 2 years, we included 222 full-term neonates who had early onset group B streptococcal disease responsive to 48 h of intravenous amoxicillin, at which point they were asymptomatic and fed orally. They were switched to oral amoxicillin (300 or 200 mg/kg per day in four divided doses). Steady-state serum amoxicillin concentrations were determined 48 h later by high-performance liquid chromatography; values ≥5 mg/l were considered effective.
Results
Mean gestational age was 39.32 ± 1.5 weeks ,and mean birth weight was 3,422 ± 533 g; 29 newborns were bacteremic. Median serum amoxicillin concentration on oral therapy was 31,.15 (range 11–118) and 25.80 (range 5–84.8) with 300 and 200 mg/kg per day, respectively. None of the infants had a concentration <5 mg/l (p < 0.001). Gastrointestinal tolerance was satisfactory; 216 patients were discharged at 5 days of age, and none was readmitted within the 3-month follow-up.
Conclusion
Early switching to the oral route in asymptomatic full-term newborns with early onset group B streptococcal disease maintained serum amoxicillin concentrations within our predefined therapeutic range (error risk<0.001). This strategy may hold potential for reducing treatment invasiveness and shortening hospital length of stay.
Similar content being viewed by others
References
Klein JO, Remington JS (2001) Current concepts of infections of the fetus and newborn infant. In: Remington JS, Klein JO (eds) Textbook of infectious diseases of the fetus and newborn infant, 5th edn. W.B. Saunders Company, Philadelphia, pp 1–23
Alarcon A, Pena P, Salas S, Sancha M, Omenaca F (2004) Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis. Pediatr Infect Dis 23(4):295–299
American Academy of Pediatrics (2006) Group B streptococcal infections. In: Pickering LK, Baker CJ, Long SS, Mc Millan JA (eds). Red Book: 2006 report of the Committee of Infectious Diseases, 27th ed. American Academy of Pediatrics, Elk Grove Village, pp 620–627
Heimann G (1980) Enteral absorption and bioavailability in children in relation to age. Eur J Clin Pharmacol 18:43–50
Sevinc F, Prins JM, Koopmans RP (1999) Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother 43:601–606
Kern WV, Cometta A, De Brok R (1999) For the international antimicrobial cooperative group of the european organization for research and treatment of cancer. Oral versus intravenous empirical antimicrobial therapy for fever in patient with granulocytopenia who are receiving cancer chemotherapy. N Engl J Med 341:312–318
Cohen MD, Raeburn JA, Devine J, Kirkwood J, Elliott B, Cockburn F, Forfar JO (1975) Pharmacology of some oral penicillins in the newborn infant. Arch Dis Child 50(3):230–234
Autret E, Laugier J, Marimbu J, Vaillant MC, Furet Y, Breteau M (1988) Comparaison des concentrations plasmatiques d’amoxicilline par voie orale et intraveineuse dans les colonisations bactériennes néonatales. Arch Fr Pediatr 45(9):679–682
Giustardi A, Coppola G (1992) Comparison of plasma concentrations of amoxicillin administered by oral and venous routes in neonatal bacterial colonizations. Pediatr Med Chir 114:447–449
Puopolo KM, Madoff LC, Eichenwald EC (2005) Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 115(5):1240–1246
Haque KN (2005) Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med 6(3 Suppl):S45–S49
Jehl F, Birckel P, Monteil H (1987) Hospital routine analysis of penicillins, third-generation cephalosporins and aztreonam by conventional and high-speed high-performance liquid chromatography. J Chromatogr 23(413):109–119
Shaffer Cl, Davey Am, Ransom Jl (1998) Ampicillin-induced neurotoxicity in very-low-birth-weight neonates. Ann Pharmacother 32:482–484
Huisman-de Boer JJ, van den Anker JN, Vogel M, Goessens WH, Schoemaker RC, de Groot R (1995) Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks. Antimicrob Agents Chemother 39(2):431–434
Heimann G (1980) Enteral absorption and bioavailability in children in relation to age. Eur J Clin Pharmacol 18:43–50
Seelig MS (1966) The role of antibiotics in the pathogenesis of Candida infections. Am J Med 40:887–917
Oudesluys-Murphy AM, de Groot CJ, Eilers GA (1986) Time of umbilical cord separation. J Pediatr 108(2):334
Nord C, Kager L, Heimdahl P (1984) Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infection. Am J Med 23:99–106
Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118(2):511–521
McCracken GH (1983) Comparative evaluation of the aminopenicillins for oral use. Pediatr Infect Dis 2:317–320
Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K (2002) Nurse-staffing levels and the quality of care in hospitals. N Engl J Med 30(346):1715–1722
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gras-Le Guen, C., Boscher, C., Godon, N. et al. Therapeutic amoxicillin levels achieved with oral administration in term neonates. Eur J Clin Pharmacol 63, 657–662 (2007). https://doi.org/10.1007/s00228-007-0307-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-007-0307-3